AON — Aon plc

The market is leaning positive after Aon's Q2 2026 beat: adjusted EPS of $3.81 versus $3.80 consensus, organic revenue growth of 5% across all four solution lines, and reaffirmed FY2026 guidance for mid-single-digit or better organic growth, 70–80bps of margin expansion, and double-digit FCF growth. Multiple banks raised price targets in late July/August 2026, and Aon returned $775M to shareholders in Q2 alone, including $600M of buybacks.

Revenue growth has decelerated from the inorganic-boosted 2024 pace: 2026 Q2 headline revenue rose only 2% YoY to $4.25B, though organic growth was 5%; 2026 Q1 revenue was up 6.4% YoY to $5.03B. Operating margins are structurally improving — H1 2026 operating income of $2.63B on $9.28B revenue gives roughly 28.4% margin versus 27.5% in H1 2025 — and management is guiding for further full-year expansion. Q4 2025 net income of $1.69B and EPS of $7.82 were flattered by one-off items, so TTM EPS of $18.31 overstates the run-rate. Quarterly FCF is lumpy: Q2 2026 FCF fell to $483M from $732M a year earlier, but H1 2026 FCF of $846M is still up modestly from $816M in H1 2025.

Aon is cheap relative to its own history but not objectively cheap on absolute multiples. As of 2026-08-27, trailing P/E is 19.16, forward P/E is roughly 18.3x the next-FY EPS estimate of $19.08, and P/S is 4.22 versus the 5-year averages of 30.12x earnings and 4.86x sales. The PEG of 0.37 looks gimmicky because it is based on a distorted trailing growth rate; the more realistic read is a high-quality compounder trading at a meaningful discount to its historical multiple, supported by 27.2% operating margin, 22.3% net margin, and 12.2% ROIC.

Price has de-rated from historical highs even as consensus EPS estimates keep edging up, which is why the stock sits below both the $408.71 consensus target and the recent average target of $393. The market is currently pricing in sluggish headline revenue growth and P&C rate softening rather than a strong re-rating. If Aon delivers the guided EPS growth, margin expansion, and double-digit FCF growth, the multiple can reasonably expand toward 20–22x; if organic growth slips below 5% or reinsurance pricing keeps softening, the current 18–19x multiple is about fair.

As of 2026-08-27, Aon is range-bound and technically neutral: RSI-14 is 45.6, price is 1.5% below the 20-day SMA, 0.7% below the 50-day SMA, and 3.5% above the 200-day SMA. The stock sits well within its 52-week range of $304.59–$382.34 after fading from the high. The implication for entry timing is that there is no oversold bounce setup or fresh breakout; waiting for a reclaim of the 50-day or a pullback toward the 200-day would offer a cleaner risk/reward.

• P&C and reinsurance rate softening — treaty pricing down 15–20% in some pockets — pressures organic growth, though Aon is offsetting with new business and record ILS activity.
• M&A volumes are up more than 60% from the prior trough, a direct tailwind for Aon's Transaction Solutions and commercial advisory lines.
• U.S. employer healthcare costs are projected to rise 9.5% in 2027, lifting demand for Aon's Health Solutions advisory and brokerage.
• Interest rates staying elevated supports investment income on float but also keeps financing costs high on Aon's $12.95B of long-term debt.
• AI/data-center buildout is creating a fast-growing insurance capacity niche; Aon scaled data-center capacity to $5B and launched Sidecar X with $200M of secured capacity.

• Q3 2026 earnings on October 30, 2026 — consensus EPS around $3.39; watch for M&A fee acceleration and margin progress.
• Continued execution of the 3x3 Plan and Aon Business Services restructuring: $100M structural savings in 2026 and $450M total by 2027.
• Aggressive capital returns: YTD buybacks already exceeded the initial $1B full-year target, with $600M repurchased in Q2 alone.
• Expansion into digital infrastructure insurance and Sidecar X could provide a fresh growth narrative if capacity scales quickly.

• Reinsurance treaty pricing softening could slow organic growth in the largest commercial risk and reinsurance lines.
• Headline revenue growth was only 2% YoY in Q2 2026; any slip below 5% organic growth would undermine the bull case.
• High leverage remains a constraint: long-term debt of $12.95B and debt/equity of 1.64 leave limited balance-sheet flexibility if rates stay high.
• TTM EPS is inflated by the one-off Q4 2025 item, so naively using $18.31 to value the stock overstates run-rate earnings power.
• A sustained rise in rates or an M&A-driven debt increase could compress the multiple despite good operating fundamentals.

Aon is a high-quality, moaty insurance broker with strong margins, 12.2% ROIC, and credible tailwinds from M&A recovery, healthcare cost inflation, and data-center risk demand. But the backward-looking deterministic score correctly flags weak recent growth momentum, and Q2 2026's headline revenue and cash-flow lumpiness argue against chasing strength here. At $349.56, it is more of an accumulate-on-weakness name than an urgent buy, and the weak-fundamentals-plus-cheap-valuation mapping makes the required lean Cautiously Bearish.

Calculated as 20.5x forward EPS of $19.08, a discount to Aon's 5-year average P/E of 30.1 but a premium to its current ~18.3x forward multiple, justified by 27.2% operating margin, 12.2% ROIC, and mid-single-digit organic growth; a ~4.6x P/S cross-check on 2026 revenue lands in the same zone.